Plexus (NASDAQ:PLXS) Updates Q1 2025 Earnings Guidance

Plexus (NASDAQ:PLXS) updated its first quarter 2025 earnings guidance on Wednesday. The company provided EPS guidance of 1.520-1.670 for the period, compared to the consensus EPS estimate of 1.540. The company issued revenue guidance of $960.0 million-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion. Plexus also updated its Q1 guidance to $1.52-$1.67 EPS.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. Benchmark restated a “buy” rating and issued a $150.00 target price on shares of Plexus in a research note on Monday. KeyCorp assumed coverage on shares of Plexus in a research note on Tuesday. They issued a “sector weight” rating for the company. Finally, Needham & Company LLC increased their price target on Plexus from $114.00 to $144.00 and gave the stock a “buy” rating in a research report on Friday, July 26th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Plexus presently has a consensus rating of “Hold” and a consensus price target of $125.25.

Plexus Price Performance

NASDAQ:PLXS traded up $0.79 during mid-day trading on Wednesday, reaching $135.57. 94,509 shares of the company were exchanged, compared to its average volume of 126,165. Plexus has a 12 month low of $87.21 and a 12 month high of $139.98. The stock has a market cap of $3.69 billion, a PE ratio of 34.15 and a beta of 0.89. The company has a quick ratio of 0.64, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company has a fifty day moving average of $129.74 and a 200 day moving average of $115.48.

Plexus (NASDAQ:PLXS) last posted its quarterly earnings data on Wednesday, July 24th. The technology company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.17. Plexus had a net margin of 2.82% and a return on equity of 9.64%. The firm had revenue of $960.70 million during the quarter, compared to analysts’ expectations of $981.32 million. During the same quarter in the previous year, the company posted $1.32 EPS. Plexus’s revenue was down 6.0% on a year-over-year basis. On average, research analysts anticipate that Plexus will post 3.74 EPS for the current fiscal year.

Insider Activity

In other Plexus news, Director Karen Marie Rapp sold 500 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $128.02, for a total transaction of $64,010.00. Following the transaction, the director now directly owns 9,586 shares in the company, valued at approximately $1,227,199.72. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Plexus news, Director Karen Marie Rapp sold 500 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $128.02, for a total transaction of $64,010.00. Following the completion of the sale, the director now owns 9,586 shares in the company, valued at approximately $1,227,199.72. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Steven J. Frisch sold 6,565 shares of the firm’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $128.11, for a total value of $841,042.15. Following the completion of the transaction, the insider now owns 36,118 shares in the company, valued at $4,627,076.98. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 20,113 shares of company stock valued at $2,541,394. Company insiders own 2.39% of the company’s stock.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.